The work of the COVID Moonshot Consortium is being published in the prestigious journal Science on 10 November, revealing their discovery of a potent SARS-CoV-2 antiviral lead compound. It also reflects on the success of its open science approach in launching a patent-free antiviral discovery program to rapidly develop a differentiated lead in response to
The U.S. Food and Drug Administration approved Adzynma, the first recombinant (genetically engineered) protein product indicated for prophylactic (preventive) or on demand enzyme replacement therapy (ERT) in adult and pediatric patients with congenital thrombotic thrombocytopenic purpura (cTTP), a rare and life-threatening blood clotting disorder. “The FDA remains deeply committed in our efforts to help facilitate
November the 10th a panel of international experts representing the World Health Organization’s Guideline Development Group has updated its guidance on treatments for patients with COVID-19. The new recommendations published by The BMJ are part of a living guideline, developed by the World Health Organization with the methodological support of MAGIC Evidence Ecosystem Foundation, to provide up
Cardiovascular, kidney and metabolic health measures included in new PREVENT risk calculator, detailed in a new American Heart Association Scientific Statement Statement Highlights: A new calculator estimates a person’s risk for cardiovascular disease (CVD) over the next 30 years by combining measures of cardiovascular, kidney and metabolic health for the first time, according to a
Gait impairment can be a significant challenge as Parkinson’s disease (PD) advances, with balance problems, frequent falls, and freezing of gait impeding quality of life. Often these challenges do not respond to increased amounts of PD medication or deep brain stimulation (DBS). In recent years, electrical stimulation of the spinal cord has been a research
Hospitalization rates in people with saline regimens significantly lower than in reference population As Covid and its health effects move into a fourth year, those who become infected may be searching for remedies to improve their respiratory symptoms and keep them out of the hospital. A new study being presented at this year’s American College
Characterized by extensive damage to joints and debilitating pain, osteoarthritis (OA) impacts millions of people worldwide and has long posed a substantial clinical and economic burden. In spite of advances in diagnosis, medications, and short-term pain management solutions, the elusive goal of a disease-modifying OA drug has remained out of reach. In recent years though,
DECREASED RISK FOUND AFTER MRNA VACCINE Having a COVID-19 infection is associated with an increased risk of developing the rare disorder called Guillain-Barré syndrome within the next six weeks, according to a study published in the October 18, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study also
Tens of thousands of people in England may have lasting symptoms from COVID‐19 more than a year after infection, new analysis reveals. The findings come from a representative sample of more than a quarter of a million people in England surveyed as part of the REACT study, who self-reported their symptoms and the impact of COVID-19
Clocking up just 20–25 minutes of physical activity every day may be enough to offset the heightened risk of death from a highly sedentary lifestyle, suggests research published online in the British Journal of Sports Medicine. But higher daily tallies of physical activity are linked to a lower risk, irrespective of the amount of time spent
